Influence of repetitive contrast agent injections on functional and molecular ultrasound measurements

Ultrasound in Medicine and Biology

Volumn 40, Issue 10, 2014, Pages 2468-2475

  Rix, Anne ^a   Palmowski, Moritz ^a,b   Gremse, Felix ^a   Palmowski, Karin ^c   Lederle, Wiltrud ^a   Kiessling, Fabian ^a   Bzyl, Jessica ^a  

^a RWTH AACHEN UNIVERSITY   (Germany)

^b UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^c UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Cancer; Contrast enhanced ultrasound; Molecular ultrasound; Multiple injections; Peak enhancement; Quantitative imaging; Reproducibility; SonoVue; Time to peak; Vascular endothelial growth factor receptor 2; VEGFR2

Indexed keywords

BINDING SITES; TUMORS; ULTRASONICS;

CANCER; CONTRAST ENHANCED ULTRASOUND; MULTIPLE INJECTIONS; QUANTITATIVE IMAGING; REPRODUCIBILITIES; SONOVUE; TIME TO PEAK; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR; VEGFR-2;

MOLECULAR IMAGING;

SONOVUE; VASCULOTROPIN RECEPTOR 2; CONTRAST AGENT BR1; CONTRAST MEDIUM; PHOSPHOLIPID; SULFUR HEXAFLUORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BINDING SITE; BIOACCUMULATION; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DOSE RESPONSE; DRUG PROTEIN BINDING; ECHOGRAPHY; FEMALE; FUNCTIONAL ASSESSMENT; MICROBUBBLE; MICROINJECTION; MOLECULAR IMAGING; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN TARGETING; QUALITY CONTROL; REPEATED DRUG DOSE; SQUAMOUS CELL CARCINOMA; ANIMAL; IMAGE ENHANCEMENT; INJECTION; LIVER; METABOLISM; NUDE MOUSE; PROCEDURES; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY;

ANIMALS; CARCINOMA, SQUAMOUS CELL; CONTRAST MEDIA; FEMALE; IMAGE ENHANCEMENT; INJECTIONS; LIVER; MICE; MICE, NUDE; MICROBUBBLES; MOLECULAR IMAGING; PHOSPHOLIPIDS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SULFUR HEXAFLUORIDE; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

EID: 84926260753     PISSN: 03015629     EISSN: 1879291X     Source Type: Journal    
DOI: 10.1016/j.ultrasmedbio.2014.04.010     Document Type: Article

References (23)

1. Bzyl J., Lederle W., Rix A., Grouls C., Tardy I., Pochon S., Siepmann M., Penzkofer T., Schneider M., Kiessling F., Palmowski M. Molecular and functional ultrasound imaging in differently aggressive breast cancer xenografts using two novel ultrasound contrast agents (BR55 and BR38). Eur Radiol 2011, 21:1988-1995.
2. Bzyl J., Palmowski M., Rix A., Arns S., Hyvelin J.M., Pochon S., Ehling J., Schrading S., Kiessling F., Lederle W. The high angiogenic activity in very early breast cancer enables reliable imaging with VEGFR2-targeted microbubbles (BR55). Eur Radiol 2013, 23:468-475.
3. Claudon M., Dietrich C.F., Choi B.I., Cosgrove D.O., Kudo M., Nolsøe C.P., Piscaglia F., Wilson S.R., Barr R.G., Chammas M.C., Chaubal N.G., Chen M.H., Clevert D.A., Correas J.M., Ding H., Forsberg F., Fowlkes J.B., Gibson R.N., Goldberg B.B., Lassau N., Leen E.L., Mattrey R.F., Moriyasu F., Solbiati L., Weskott H.P., Xu H.X. Guidelines and good clinical practice recommendations for contrast enhanced ultrasound (CEUS) in the liver-Update 2012: A WFUMB-EFSUMB initiative in cooperation with representatives of AFSUMB, AIUM, ASUM, FLAUS and ICUS. Ultrasound Med Biol 2013, 39:187-210.
4. Dietrich C.F., Averkiou M.A., Correas J.M., Lassau N., Leen E., Piscaglia F. An EFSUMB introduction into dynamic contrast-enhanced ultrasound (DCE-US) for quantification of tumour perfusion. Ultraschall Med 2012, 33:344-351.
5. Fokong S., Theek B., Wu Z., Koczera P., Appold L., Jorge S., Resch-Genger U., van Zandvoort M., Storm G., Kiessling F., Lammers T. Image-guided, targeted and triggered drug delivery to tumors using polymer-based microbubbles. JControl Release 2012, 163:75-81.
6. Gerhardt H., Golding M., Fruttiger M., Ruhrberg C., Lundkvist A., Abramsson A., Jeltsch M., Mitchell C., Alitalo K., Shima D., Betsholtz C. VEGF guides angiogenic sprouting utilizing endothelial tip cell filopodia. JCell Biol 2003, 161:1163-1177.
7. Grouls C., Hatting M., Rix A., Pochon S., Lederle W., Tardy I., Kuhl C.K., Trautwein C., Kiessling F., Palmowski M. Liver dysplasia: US molecular imaging with targeted contrast agent enables early assessment. Radiology 2013, 267:487-495.
8. Kiessling F., Bzyl J., Fokong S., Siepmann M., Schmitz G., Palmowski M. Targeted ultrasound imaging of cancer: An emerging technology on its way to clinics. Curr Pharm Des 2012, 18:2184-2199.
9. Kundavaram C.R., Halpern E.J., Trabulsi E.J. Value of contrast-enhanced ultrasonography in prostate cancer. Curr Opin Urol 2012, 22:303-309.
10. Lassau N., Chebil M., Chami L., Bidault S., Girard E., Roche A. Dynamic contrast-enhanced ultrasonography (DCE-US): A new tool for the early evaluation of antiangiogenic treatment. Target Oncol 2010, 5:53-58.
11. Lassau N., Koscielny S., Chami L., Chebil M., Benatsou B., Roche A., Ducreux M., Malka D., Boige V. Advanced hepatocellular carcinoma: Early evaluation of response to bevacizumab therapy at dynamic contrast-enhanced US with quantification-Preliminary results. Radiology 2011, 258:291-300.
12. Miller D.L., Quddus J. Diagnostic ultrasound activation of contrast agent gas bodies induces capillary rupture in mice. Proc Natl Acad Sci USA 2000, 97:10179-10184.
13. Palmowski M., Lederle W., Gaetjens J., Socher M., Hauff P., Bzyl J., Semmler W., Günther R.W., Kiessling F. Comparison of conventional time-intensity curves vs. maximum intensity over time for post-processing of dynamic contrast-enhanced ultrasound. Eur J Radiol 2010, 75:e149-e153.
14. Pochon S., Tardy I., Bussat P., Bettinger T., Brochot J., von Wronski M., Passantino L., Schneider M. BR55: A lipopeptide-based VEGFR2-targeted ultrasound contrast agent for molecular imaging of angiogenesis. Invest Radiol 2010, 45:89-95.
15. Pries A.R., Secomb T.W., Gaehtgens T. The endothelial surface layer. Pfluegers Arch 2000, 440:653-666.
16. Pysz M.A., Foygel K., Rosenberg J., Gambhir S.S., Schneider M., Willmann J.K. Antiangiogenic cancer therapy: Monitoring with molecular US and a clinically translatable contrast agent (BR55). Radiology 2010, 256:519-527.
17. Schneider M., Broillet A., Tardy I., Pochon S., Bussat P., Bettinger T., Helbert A., Costa M., Tranquart F. Use of intravital microscopy to study the microvascular behavior of microbubble-based ultrasound contrast agents. Microcirculation 2012, 19:245-259.
18. Szczesny G., Veihelmann A., Massberg S., Nolte D., Messmer K. Long-term anaesthesia using inhalatory isoflurane in different strains of mice: The haemodynamic effects. Lab Anim 2004, 38:64-69.
19. Szebeni J., Muggia F., Gabizon A., Barenholz Y. Activation of complement by therapeutic liposomes and other lipid excipient-based therapeutic products: Prediction and prevention. Adv Drug Deliv Rev 2011, 63:1020-1030.
20. Tardy I., Pochon S., Theraulaz M., Emmel P., Passantino L., Tranquart F., Schneider M. Ultrasound molecular imaging of VEGFR2 in a rat prostate tumor model using BR55. Invest Radiol 2010, 45:573-578.
21. Weskott H.P. Emerging roles for contrast-enhanced ultrasound. Clin Hemorheol Microcirc 2008, 40:51-71.
22. Weskott H.P. Detection and characterization of liver metastases. Radiologe 2011, 51:469-474.
23. Wijkstra H, Smeenge M, de la Rosette J, Pochon S, Tardy-Cantalupi I, Tranquart F. Targeted microbubble prostate cancer imaging with BR55. In: Proceedings, 17th Symposium on Ultrasound Contrast Imaging, Rotterdam, The Netherlands, 19-20 January 2012 [Abstract]. Rotterdam: Erasmus MC, London: Imperial College,2012.